The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

iCAD gets FDA nod for colon cancer detection product

August 5, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Nashua, N.H.-based image and analysis solutions company iCAD Inc. has announced that the U.S. Food and Drug Administration has approved the company's VeraLook computer-aided detection product used to analyze virtual colonoscopy exams.

Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010

August 5, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

NEWTON, Mass. , Aug. 5 /- Microfluidics International Corporation (OTC Bulletin Board: MFLU ) announced today the Company will release second quarter 2010 financial results on Tuesday, August 10, 2010 , at 8:30am ET . (Logo: )...


JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company

August 5, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

CLEVELAND , Aug. 5 /- JumpStart Ventures , which invests in and partners with innovative, early-stage companies in Northeast Ohio , announced an investment commitment of $250,000 in drug development company ChanRx. The two-year-old company is developing a pharmaceutical compound to treat...


Cornerstone Therapeutics Announces Development of Generic for Tussionex®

August 5, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

CARY, N.C. , Aug. 5 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its...


Diagnostics firm Ikonisys lands $3.8M

August 5, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ikonisys Inc., a New Haven, Conn.-based diagnostics device firm, has raised $3.8 million of a planned $12 million equity and warrants offering, according to a regulatory filing. The company develops a platform that serves as the basis of diagnostic products for identifying cancer and birth defects.


Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine

August 5, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, California , and AMSTERDAM , August 5, 2010 /- Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington...


Omnicare 2Q net income falls, shares drop

August 5, 2010 7:45 am | by The Associated Press | News | Comments

Omnicare Inc. said Thursday its net income fell 60 percent in the second quarter on lower pharmacy services revenue.The company, which dispenses drugs to nursing homes and long-term care facilities, also cut its outlook for the year, helping to send its shares down 11 percent in morning trading...

Thermocouple and RTD Thermometers Offer High Accuracy, Data Logging

August 5, 2010 6:06 am | Product Releases | Comments

There are 3 display locations on the large, easy-to-read LCD that displays the temperatures and differences of the two inputs, as well as the specific function when in use.


Connector Headers Designed for CFast Card Interface

August 5, 2010 5:47 am | Product Releases | Comments

Fully compliant to the CFast standard, 3M Headers for CFast meet the CFA CFast Specification Rev 1.0 and offer many features and options for PCB designers seeking to implement CFast technology.

Thermal Interface Materials Manufactured With Hardened Top Surface

August 5, 2010 5:39 am | Product Releases | Comments

Fujipoly has added Sarcon 100GR-HL to its line of specially formulated thermal interface materials. This advanced gap filler pad is manufactured with a hardened top surface.

Making Spider-Strength Materials

August 5, 2010 5:37 am | by Massachusetts Institute of Technology | News | Comments

Genetically modified bacteria can produce enough proteins for super-strong spider silk.

ImmunoGen sees sharp revenue drop for fiscal 2010

August 5, 2010 5:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Waltham biotech ImmunoGen Inc. ended its fiscal 2010 with less than half of the revenue it reported for fiscal 2009, mainly due to a drop in license and milestone fee revenue.

Draft Guidance for Industry and Food and Drug Administration Staff - Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays

August 5, 2010 5:36 am | by U.S. Food & Drug Administration | News | Comments

These assays are intended to quantitatively measure concentrations of the respective drugs in serum or plasma as an aid in the management of patients treated with lamotrigine or zonisamide. The recommendations are based on current review practices as...


In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Ne...

August 5, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass. , Aug. 5 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection (CDI), nearly 70 percent of surveyed infectious disease...


Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results

August 5, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

BEIJING , Aug. 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading developer and provider of vaccines in China , announced today that it will release its financial results for the second quarter ended June 30, 2010 before the open of the market on Monday, August 16, 2010...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.